Department of Psychiatry
Michael Caligiuri has not added Biography.
If you are Michael Caligiuri and would like to personalize this page please email our Author Liaison for assistance.
The role of STAT1 in viral sensitization to LPS.
Journal of endotoxin research , 2003 | Pubmed ID: 14577848
BAALC, a novel marker of human hematopoietic progenitor cells.
Experimental hematology Nov, 2003 | Pubmed ID: 14585369
A quantitative neuromotor predictor of antidepressant non-response in patients with major depression.
Journal of affective disorders Nov, 2003 | Pubmed ID: 14607390
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2003 | Pubmed ID: 14614138
Rituximab: converging mechanisms of action in non-Hodgkin's lymphoma?
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2003 | Pubmed ID: 14676100
EBV kidney allograft infection: possible relationship with a peri-graft localization of PTLD.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons Jan, 2004 | Pubmed ID: 14678042
NK cell and DC interactions.
Trends in immunology Jan, 2004 | Pubmed ID: 14698284
Loss of C/EBP alpha and favorable prognosis of acute myeloid leukemias: a biological paradox.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb, 2004 | Pubmed ID: 14726508
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Lancet Feb, 2004 | Pubmed ID: 14975618
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2004 | Pubmed ID: 15007164
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
Blood Jul, 2004 | Pubmed ID: 15016654
A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder.
Bipolar disorders Jun, 2004 | Pubmed ID: 15117397
Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements?
Journal of clinical psychopharmacology Jun, 2004 | Pubmed ID: 15118484
Association of diabetes with dyskinesia in older psychosis patients.
Psychopharmacology Nov, 2004 | Pubmed ID: 15138754
AIDS-associated malignancies.
Cancer chemotherapy and biological response modifiers , 2003 | Pubmed ID: 15338771
Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease.
Blood Jan, 2005 | Pubmed ID: 15374888
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2004 | Pubmed ID: 15447996
Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma.
Advances in pharmacology (San Diego, Calif.) , 2004 | Pubmed ID: 15464915
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Journal of the National Cancer Institute Oct, 2004 | Pubmed ID: 15467034
A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
Genomics Oct, 2004 | Pubmed ID: 15475242
Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies.
Blood Feb, 2005 | Pubmed ID: 15486062
IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.
Blood Feb, 2005 | Pubmed ID: 15498860
Functional brain asymmetries during visuomotor tracking.
Journal of clinical and experimental neuropsychology May, 2004 | Pubmed ID: 15512926
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2004 | Pubmed ID: 15514371
Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
Cancer research Nov, 2004 | Pubmed ID: 15520217
Immunotherapeutic approaches for hematologic malignancies.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program , 2004 | Pubmed ID: 15561691
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation.
Blood Apr, 2005 | Pubmed ID: 15604218
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
Genes, chromosomes & cancer Apr, 2005 | Pubmed ID: 15645492
Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector.
Journal of immunological methods Jan, 2005 | Pubmed ID: 15680156
Interleukin-2, interleukin-15, and their roles in human natural killer cells.
Advances in immunology , 2005 | Pubmed ID: 15705423
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.
Nature genetics Mar, 2005 | Pubmed ID: 15723065
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
Blood Jul, 2005 | Pubmed ID: 15774615
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.
Immunity Mar, 2005 | Pubmed ID: 15780987
Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients.
Schizophrenia research Jun, 2005 | Pubmed ID: 15820325
Cellular uptake and intracellular levels of the bcl-2 antisense g3139 in cultured cells and treated patients with acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2005 | Pubmed ID: 15837754
IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.
Blood Oct, 2005 | Pubmed ID: 15976176
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies.
Blood Nov, 2005 | Pubmed ID: 16037385
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
Blood Nov, 2005 | Pubmed ID: 16076875
Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Dec, 2005 | Pubmed ID: 16123755
Lateralized cognitive dysfunction and psychotic symptoms in schizophrenia.
Schizophrenia research Dec, 2005 | Pubmed ID: 16125374
The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
Molecular and cellular biology Sep, 2005 | Pubmed ID: 16135788
Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
Cancer research Oct, 2005 | Pubmed ID: 16204085
Cytokine therapy for cancer: antigen presentation.
Cancer treatment and research , 2005 | Pubmed ID: 16211874
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2005 | Pubmed ID: 16275934
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.
Cancer cell Nov, 2005 | Pubmed ID: 16286244
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation.
Blood Mar, 2006 | Pubmed ID: 16293596
EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease.
Virology Mar, 2006 | Pubmed ID: 16321417
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan, 2006 | Pubmed ID: 16344317
Human natural killer cell development and biology.
Blood reviews May, 2006 | Pubmed ID: 16364519
Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiation.
Journal of immunology (Baltimore, Md. : 1950) Feb, 2006 | Pubmed ID: 16424184
Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines.
Expert opinion on pharmacotherapy Feb, 2006 | Pubmed ID: 16433578
STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo.
European journal of immunology Mar, 2006 | Pubmed ID: 16482512
Striatopallidal regulation of affect in bipolar disorder.
Journal of affective disorders Apr, 2006 | Pubmed ID: 16503055
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN Mar, 2006 | Pubmed ID: 16507273
Autologous immune strategies to reduce the risk of leukemic relapse: consideration for IL-15.
Best practice & research. Clinical haematology , 2006 | Pubmed ID: 16516125
FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways.
Blood Jul, 2006 | Pubmed ID: 16543474
Tumor growth impedes natural-killer-cell maturation in the bone marrow.
Blood Jul, 2006 | Pubmed ID: 16556890
Recent advances in the treatment of transplant-related lymphoma.
Clinical advances in hematology & oncology : H&O Jan, 2006 | Pubmed ID: 16562366
Evidence for discrete stages of human natural killer cell differentiation in vivo.
The Journal of experimental medicine Apr, 2006 | Pubmed ID: 16606675
Immunologic approaches to acute leukemia in the elderly.
Seminars in hematology Apr, 2006 | Pubmed ID: 16616045
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr, 2006 | Pubmed ID: 16622259
Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism.
Human movement science Oct, 2006 | Pubmed ID: 16647772
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study.
Blood Sep, 2006 | Pubmed ID: 16670265
Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
Immunity May, 2006 | Pubmed ID: 16713975
Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2006 | Pubmed ID: 16740775
Cancer and leukemia group B leukemia correlative science committee: major accomplishments and future directions.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2006 | Pubmed ID: 16740786
Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity.
Blood Oct, 2006 | Pubmed ID: 16757683
A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2006 | Pubmed ID: 16818697
Impaired hemispheric communication in schizophrenia: a study using the consonant-vowel-consonant task.
Schizophrenia research Oct, 2006 | Pubmed ID: 16822652
PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics Sep, 2006 | Pubmed ID: 16838358
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Aug, 2006 | Pubmed ID: 16864058
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics.
Blood Dec, 2006 | Pubmed ID: 16902153
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2006 | Pubmed ID: 16908838
Abnormalities in motor physiology in bipolar disorder.
The Journal of neuropsychiatry and clinical neurosciences , 2006 | Pubmed ID: 16963583
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations.
The Journal of clinical investigation Oct, 2006 | Pubmed ID: 16981007
Human natural killer cell development.
Immunological reviews Dec, 2006 | Pubmed ID: 17100876
Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells.
Blood Mar, 2007 | Pubmed ID: 17110450
Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
Journal of clinical psychopharmacology Dec, 2006 | Pubmed ID: 17110811
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2006 | Pubmed ID: 17145827
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
Blood Jun, 2007 | Pubmed ID: 17341662
Internal versus external: oral-motor performance as a function of attentional focus.
Journal of speech, language, and hearing research : JSLHR Feb, 2007 | Pubmed ID: 17344554
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2007 | Pubmed ID: 17404098
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.
Blood Oct, 2007 | Pubmed ID: 17440052
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.
Blood Aug, 2007 | Pubmed ID: 17475908
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.
Blood Aug, 2007 | Pubmed ID: 17475912
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
Blood Sep, 2007 | Pubmed ID: 17494858
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia.
Blood Sep, 2007 | Pubmed ID: 17537993
Chronic lymphocytosis of functionally immature natural killer cells.
The Journal of allergy and clinical immunology Oct, 2007 | Pubmed ID: 17604094
Transcriptional control of human T-BET expression: the role of Sp1.
European journal of immunology Sep, 2007 | Pubmed ID: 17705132
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
The Journal of clinical investigation Sep, 2007 | Pubmed ID: 17717597
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.
The Journal of experimental medicine Oct, 2007 | Pubmed ID: 17875674
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
Proceedings of the National Academy of Sciences of the United States of America Sep, 2007 | Pubmed ID: 17881568
Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.
Blood Jan, 2008 | Pubmed ID: 17925491
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
Blood Feb, 2008 | Pubmed ID: 17940205
SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients.
Genes, chromosomes & cancer Mar, 2008 | Pubmed ID: 18064648
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.
Blood Feb, 2008 | Pubmed ID: 18083845
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.
Blood Apr, 2008 | Pubmed ID: 18174382
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro.
Blood May, 2008 | Pubmed ID: 18182577
Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
Journal of clinical psychopharmacology Feb, 2008 | Pubmed ID: 18204344
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2008 | Pubmed ID: 18223233
Isolation and characterization of human natural killer cell subsets.
Current protocols in immunology / edited by John E. Coligan ... [et al.] May, 2004 | Pubmed ID: 18432933
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
The New England journal of medicine May, 2008 | Pubmed ID: 18450603
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2008 | Pubmed ID: 18559874
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.
Blood Sep, 2008 | Pubmed ID: 18566324
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2008 | Pubmed ID: 18591543
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele.
Blood Sep, 2008 | Pubmed ID: 18617636
Human natural killer cells.
Blood Aug, 2008 | Pubmed ID: 18650461
TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2008 | Pubmed ID: 18768831
Natural killer cells in innate immunity and cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) Oct, 2008 | Pubmed ID: 18779751
Tumor growth decreases NK and B cells as well as common lymphoid progenitor.
PloS one , 2008 | Pubmed ID: 18784839
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2008 | Pubmed ID: 18809607
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development.
Blood Mar, 2009 | Pubmed ID: 18840707
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab.
Breast cancer research and treatment Sep, 2009 | Pubmed ID: 19051009
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells.
Blood Mar, 2009 | Pubmed ID: 19060242
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia.
British journal of haematology Mar, 2009 | Pubmed ID: 19183192
Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22.
Blood Apr, 2009 | Pubmed ID: 19244159
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia.
Blood May, 2009 | Pubmed ID: 19329776
Reformed consent: adapting to new media and research participant preferences.
IRB Mar-Apr, 2009 | Pubmed ID: 19402337
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul, 2009 | Pubmed ID: 19451432
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
Blood Sep, 2009 | Pubmed ID: 19553639
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.
Leukemia research Feb, 2010 | Pubmed ID: 19660811
Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone.
Human movement science Oct, 2009 | Pubmed ID: 19692133
CD94 defines phenotypically and functionally distinct mouse NK cell subsets.
Journal of immunology (Baltimore, Md. : 1950) Oct, 2009 | Pubmed ID: 19801519
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
Blood Jan, 2010 | Pubmed ID: 19897577
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody.
Blood Feb, 2010 | Pubmed ID: 19965644
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb, 2010 | Pubmed ID: 20026798
Purification of human NK cell developmental intermediates from lymph nodes and tonsils.
Methods in molecular biology (Clifton, N.J.) , 2010 | Pubmed ID: 20033630
Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.
mAbs Jan-Feb, 2010 | Pubmed ID: 20081380
In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2010 | Pubmed ID: 20142363
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.
Cell Mar, 2010 | Pubmed ID: 20211135
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2010 | Pubmed ID: 20368543
Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.
Psychiatry research May, 2010 | Pubmed ID: 20381875
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
Cancer cell Apr, 2010 | Pubmed ID: 20385359
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood Aug, 2010 | Pubmed ID: 20442368
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.
Blood Sep, 2010 | Pubmed ID: 20460501
Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue.
Immunity Jun, 2010 | Pubmed ID: 20620944
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood Nov, 2010 | Pubmed ID: 20656931
Immature NK cells, capable of producing IL-22, are present in human uterine mucosa.
Journal of immunology (Baltimore, Md. : 1950) Oct, 2010 | Pubmed ID: 20802153
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood Dec, 2010 | Pubmed ID: 20841507
PRDM1/Blimp-1 controls effector cytokine production in human NK cells.
Journal of immunology (Baltimore, Md. : 1950) Nov, 2010 | Pubmed ID: 20944005
The dynamic character of disguise behavior for text-based, mixed, and stylized signatures.
Journal of forensic sciences Jan, 2011 | Pubmed ID: 20950317
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2010 | Pubmed ID: 21079133
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells.
Blood Feb, 2011 | Pubmed ID: 21156847
Innate or adaptive immunity? The example of natural killer cells.
Science (New York, N.Y.) Jan, 2011 | Pubmed ID: 21212348
IκBζ augments IL-12- and IL-18-mediated IFN-γ production in human NK cells.
Blood Mar, 2011 | Pubmed ID: 21224476
A sheep in wolf's clothing.
Blood Feb, 2011 | Pubmed ID: 21292781
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr, 2011 | Pubmed ID: 21343549
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.
The Journal of clinical investigation Apr, 2011 | Pubmed ID: 21364281
The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis.
PloS one , 2011 | Pubmed ID: 21390242
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Haematologica Oct, 2011 | Pubmed ID: 21659357
LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosis.
PloS one , 2011 | Pubmed ID: 21695085
Associations between spontaneous movement abnormalities and psychotic-like experiences in the general population.
Schizophrenia research Nov, 2011 | Pubmed ID: 21782390
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Blood Oct, 2011 | Pubmed ID: 21828125
Voxel-based morphometry of patients with schizophrenia or bipolar I disorder: a matched control study.
Psychiatry research Nov, 2011 | Pubmed ID: 21924872
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.
Blood Dec, 2011 | Pubmed ID: 22031859
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Blood Dec, 2011 | Pubmed ID: 22031865
Targeted immunotherapy for acute myeloid leukemia.
Best practice & research. Clinical haematology Dec, 2011 | Pubmed ID: 22127317
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.
Blood Mar, 2012 | Pubmed ID: 22251480
Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma.
Cancer research Mar, 2012 | Pubmed ID: 22282654
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar, 2012 | Pubmed ID: 22291079
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells.
Advances in virology , 2012 | Pubmed ID: 22312364
The HDAC inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells with inhibition of STAT5/T-BET signaling and IFNγ generation.
Journal of virology Feb, 2012 | Pubmed ID: 22318143
Evidence for a stepwise program of extrathymic T cell development within the human tonsil.
The Journal of clinical investigation Apr, 2012 | Pubmed ID: 22378041
MiR-155 regulates IFN-γ production in natural killer cells.
Blood Feb, 2012 | Pubmed ID: 22378844
Regulation of acute graft-versus-host disease by microRNA-155.
Blood Mar, 2012 | Pubmed ID: 22408260
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Blood Jul, 2012 | Pubmed ID: 22529287
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia.
Blood Jun, 2012 | Pubmed ID: 22566605
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
Blood Aug, 2012 | Pubmed ID: 22674806
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.
Blood Aug, 2012 | Pubmed ID: 22677130
Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
Blood Aug, 2012 | Pubmed ID: 22740449
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2012 | Pubmed ID: 22753494
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep, 2012 | Pubmed ID: 22753902
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia.
Blood Sep, 2012 | Pubmed ID: 22786882
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.
The Journal of clinical investigation Aug, 2012 | Pubmed ID: 22820288
Quantitative assessment of motor abnormalities in untreated patients with major depressive disorder.
Journal of affective disorders Mar, 2013 | Pubmed ID: 22985485
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.
Blood Nov, 2012 | Pubmed ID: 23033266
Nonadherence to the isochrony principle in forged signatures.
Forensic science international Nov, 2012 | Pubmed ID: 23084659
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood Jan, 2013 | Pubmed ID: 23100311
Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation.
Cancer cell Nov, 2012 | Pubmed ID: 23153537
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Blood Jan, 2013 | Pubmed ID: 23160462
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.
Nature medicine Dec, 2012 | Pubmed ID: 23178246
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway.
Blood Jan, 2013 | Pubmed ID: 23223432
Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic target.
Blood Mar, 2013 | Pubmed ID: 23321254
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar, 2013 | Pubmed ID: 23382473
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2013 | Pubmed ID: 23418626
Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.
Blood Apr, 2013 | Pubmed ID: 23422749
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2013 | Pubmed ID: 23493348
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.
Journal of hematology & oncology , 2013 | Pubmed ID: 23497456
MicroRNAs activate natural killer cells through Toll-like receptor signaling.
Blood Jun, 2013 | Pubmed ID: 23580661
Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun, 2013 | Pubmed ID: 23650424
Axl/Gas6 pathway positively regulates FLT3 activation in human natural killer cell development.
European journal of immunology Oct, 2013 | Pubmed ID: 23722894
Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy.
Oncoimmunology Apr, 2013 | Pubmed ID: 23734319
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline.
Haematologica Aug, 2013 | Pubmed ID: 23753029
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Blood Oct, 2013 | Pubmed ID: 23886836
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Blood Sep, 2013 | Pubmed ID: 23926298
Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
Schizophrenia research Oct, 2013 | Pubmed ID: 23938173
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.
Blood Oct, 2013 | Pubmed ID: 23970380
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.
The Journal of clinical investigation Oct, 2013 | Pubmed ID: 23999433
Location and cellular stages of natural killer cell development.
Trends in immunology Sep, 2013 | Pubmed ID: 24055329
Eradicating acute myeloid leukemia in a MllPTD/wt:Flt3ITD/wt murine model: a path to novel therapeutic approaches for human disease.
Blood Oct, 2013 | Pubmed ID: 24085765
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved